ELLEN MILLER SONET was named chief strategy and alliance officer of CancerCare.
JOHN BIRKMEYER was named executive vice president for enterprise support services for the Dartmouth-Hitchcock health system.
KEVIN FITZGERALD, a Jesuit priest, Georgetown bioethicist and cancer researcher, has been appointed by Pope Francis to serve as a consultor to the Pontifical Council for Culture.
V. CRAIG JORDAN will join MD Anderson Cancer Center as a professor in Breast Medical Oncology and Molecular and Cellular Oncology. He will begin work in October.
The Department of Defense appropriations measure for the fiscal year 2015, approved by the Senate Appropriations Committee July 17, decreased overall funding for peer-reviewed cancer research programs by 4.5 percent.
Sen. Tom Harkin introduced a bill that would set NIH on a path to recoup the purchasing power it has lost since 2003, and make funding biomedical research a national priority.
More women would die from open surgery each year if the FDA decides to ban power morcellation, said Jubilee Brown, an associate professor at MD Anderson Cancer Center and a spokesperson of the American Association of Gynecologic Laparoscopists.
There was no formal consensus on either an outright ban on power morcellators or issuance of a “black box” warning label.
REP. HENRY WAXMAN received the Lifetime Achievement Award from The 340B Coalition.
MD Anderson Cancer Center's uninterrupted seven-year stretch as the top cancer hospital in the U.S. News & World Report rankings has come to an end.